These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 35637381)

  • 1. Cardiac metabolic remodelling in chronic kidney disease.
    Patel N; Yaqoob MM; Aksentijevic D
    Nat Rev Nephrol; 2022 Aug; 18(8):524-537. PubMed ID: 35637381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations.
    Law JP; Pickup L; Pavlovic D; Townend JN; Ferro CJ
    J Hum Hypertens; 2023 Jan; 37(1):1-19. PubMed ID: 36138105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and metabolic adaptation in uraemic cardiomyopathy.
    Smith K; Semple D; Aksentijevic D; Bhandari S; Seymour AM
    Front Biosci (Elite Ed); 2010 Jun; 2(4):1492-501. PubMed ID: 20515820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance.
    Edwards NC; Moody WE; Chue CD; Ferro CJ; Townend JN; Steeds RP
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):703-14. PubMed ID: 25034920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiac magnetic resonance and uremic cardiomyopathy].
    Di Lullo L; Gorini A; Rivera R; De Pascalis A; Bellasi A; Russo D; Barbera V; Ronco C; Balducci A; Santoboni A
    G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-oxidative priming but maintained cardiac function in a broad spectrum of murine models of chronic kidney disease.
    Wollenhaupt J; Frisch J; Harlacher E; Wong DWL; Jin H; Schulte C; Vondenhoff S; Moellmann J; Klinkhammer BM; Zhang L; Baleanu-Curaj A; Liehn EA; Speer T; Kazakov A; Werner C; van der Vorst EPC; Selejan SR; Hohl M; Böhm M; Kramann R; Biessen EAL; Lehrke M; Marx N; Jankowski J; Maack C; Boor P; Prates Roma L; Noels H
    Redox Biol; 2022 Oct; 56():102459. PubMed ID: 36099852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100/Calgranulin-mediated inflammation accelerates left ventricular hypertrophy and aortic valve sclerosis in chronic kidney disease in a receptor for advanced glycation end products-dependent manner.
    Yan L; Mathew L; Chellan B; Gardner B; Earley J; Puri TS; Hofmann Bowman MA
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1399-411. PubMed ID: 24855059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular basis of uraemic cardiomyopathy: a role for erythropoietin?
    Smith K; Semple D; Bhandari S; Seymour AM
    Eur J Heart Fail; 2009 Aug; 11(8):732-8. PubMed ID: 19633100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212.
    Sárközy M; Gáspár R; Zvara Á; Siska A; Kővári B; Szűcs G; Márványkövi F; Kovács MG; Diószegi P; Bodai L; Zsindely N; Pipicz M; Gömöri K; Kiss K; Bencsik P; Cserni G; Puskás LG; Földesi I; Thum T; Bátkai S; Csont T
    Sci Rep; 2019 Feb; 9(1):1302. PubMed ID: 30718600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is uremic cardiomyopathy a direct consequence of chronic kidney disease?
    Chinnappa S; Hothi SS; Tan LB
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):127-30. PubMed ID: 24404903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between CKD, sudden cardiac death, and ventricular arrhythmias.
    Pun PH
    Adv Chronic Kidney Dis; 2014 Nov; 21(6):480-8. PubMed ID: 25443573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic kidney disease and cardiovascular complications.
    Di Lullo L; House A; Gorini A; Santoboni A; Russo D; Ronco C
    Heart Fail Rev; 2015 May; 20(3):259-72. PubMed ID: 25344016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Metabolism in Heart Failure and Implications for Uremic Cardiomyopathy.
    Nguyen TD; Schulze PC
    Circ Res; 2023 Apr; 132(8):1034-1049. PubMed ID: 37053280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal denervation decreases susceptibility of the heart to ventricular fibrillation in a canine model of chronic kidney disease.
    Tang X; Shi L; Cui X; Yu Y; Qi T; Chen C; Tang X
    Exp Physiol; 2017 Nov; 102(11):1414-1423. PubMed ID: 28833735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microvascular dysfunction: a key step in the development of uraemic cardiomyopathy?
    Radhakrishnan A; Pickup LC; Price AM; Law JP; Edwards NC; Steeds RP; Ferro CJ; Townend JN
    Heart; 2019 Sep; 105(17):1302-1309. PubMed ID: 31239278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume.
    Kadappu KK; Abhayaratna K; Boyd A; French JK; Xuan W; Abhayaratna W; Thomas L
    J Am Soc Echocardiogr; 2016 Apr; 29(4):359-67. PubMed ID: 26743735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Myocardial Oxygenation Response to Stress in Patients With Chronic Kidney Disease.
    Parnham S; Gleadle JM; Bangalore S; Grover S; Perry R; Woodman RJ; De Pasquale CG; Selvanayagam JB
    J Am Heart Assoc; 2015 Aug; 4(8):e002249. PubMed ID: 26260054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation between hypertrophy and fibrosis in the left ventricle early after experimental kidney transplantation.
    Krebber MM; Papazova DA; Oosterhuis NR; Mokry M; Cramer MJ; Cheng C; Joles JA; Verhaar MC
    J Hypertens; 2020 Mar; 38(3):489-503. PubMed ID: 31652182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.
    Xie J; Yoon J; An SW; Kuro-o M; Huang CL
    J Am Soc Nephrol; 2015 May; 26(5):1150-60. PubMed ID: 25475745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.